Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 53

1.

The impact of different therapies on symptoms of benign prostatic hyperplasia: a prospective study.

Kawachi I, Barry MJ, Giovannucci E, Rimm EB, Colditz GA, Stampfer MJ, Willett WC.

Clin Ther. 1996 Nov-Dec;18(6):1118-27.

PMID:
9001828
3.

Monotherapy versus combination drug therapy for the treatment of benign prostatic hyperplasia.

Logan YT, Belgeri MT.

Am J Geriatr Pharmacother. 2005 Jun;3(2):103-14. Review.

PMID:
16129387
4.

Benign prostatic hyperplasia. Practical treatment guidelines.

Tammela T.

Drugs Aging. 1997 May;10(5):349-66. Review.

PMID:
9143856
5.

Terazosin. A pharmacoeconomic evaluation of its use in benign prostatic hyperplasia.

Plosker GL, Goa KL.

Pharmacoeconomics. 1997 Feb;11(2):184-97. Review.

PMID:
10165827
6.

Treatment of lower urinary tract symptoms in benign prostatic hyperplasia and its impact on sexual function.

Miner M, Rosenberg MT, Perelman MA.

Clin Ther. 2006 Jan;28(1):13-25. Review.

PMID:
16490576
7.

Treatment of benign prostatic hyperplasia. A pharmacoeconomic perspective.

Eri LM, Tveter KJ.

Drugs Aging. 1997 Feb;10(2):107-18. Review.

PMID:
9061268
8.

5alpha-reductase inhibitors: what role should they play?

Kaplan SA.

Urology. 2001 Dec;58(6 Suppl 1):65-70; discussion 70. Review.

PMID:
11750255
9.
10.
11.

Benign prostatic hyperplasia progression and its impact on treatment.

Djavan B, Waldert M, Ghawidel C, Marberger M.

Curr Opin Urol. 2004 Jan;14(1):45-50. Review.

PMID:
15091050
12.

Treatment of benign prostatic hyperplasia: surgery, medical therapy, or watchful waiting.

Sall M, Bruskewitz RC.

Compr Ther. 1996 Sep;22(9):554-8. Review. No abstract available.

PMID:
8902346
13.

The role of combination medical therapy in benign prostatic hyperplasia.

Greco KA, McVary KT.

Int J Impot Res. 2008 Dec;20 Suppl 3:S33-43. doi: 10.1038/ijir.2008.51. Review.

PMID:
19002123
14.

Benign prostatic hyperplasia in older men.

Gerber GS.

Clin Geriatr Med. 1998 May;14(2):317-31. Review.

PMID:
9536108
15.

What's best for your patient with BPH?

Neal RH, Keister D.

J Fam Pract. 2009 May;58(5):241-7. Review.

PMID:
19442387
16.

Benign prostatic hyperplasia in elderly men. What are the special issues in treatment?

Guthrie R.

Postgrad Med. 1997 May;101(5):141-3, 148, 151-4 passim. Review.

PMID:
9158612
17.

Diagnosis and management of benign prostatic hyperplasia.

Edwards JL.

Am Fam Physician. 2008 May 15;77(10):1403-10. Review.

18.

Initial choices and final outcomes in lower urinary tract symptoms.

Speakman MJ.

Eur Urol. 2001;40 Suppl 4:21-30. Review.

PMID:
11786676
19.

The natural history of benign prostatic hyperplasia.

Fitzpatrick JM.

BJU Int. 2006 Apr;97 Suppl 2:3-6; discussion 21-2. Review.

20.

The long-term cost effectiveness of treatments for benign prostatic hyperplasia.

DiSantostefano RL, Biddle AK, Lavelle JP.

Pharmacoeconomics. 2006;24(2):171-91. Review.

PMID:
16460137
Items per page

Supplemental Content

Write to the Help Desk